Afzal Muhammad, Nigam Gaurav Bhaskar
Gastroenterology, Royal Oldham Hospital, Oldham, Oldham, UK.
BMJ Case Rep. 2018 Jun 29;2018:bcr-2018-224963. doi: 10.1136/bcr-2018-224963.
We report this case of a 21-year-old immunocompetent man presenting with ulcerative colitis and superimposed Epstein-Barr virus (EBV) colitis. He presented for the first time with symptoms of blood-mixed diarrhoea and raised inflammatory markers. His endoscopic and histological appearances were found to be due to ulcerative colitis for which he was started on standard therapy with intravenous steroids. In spite of this, he continued to be symptomatic and his inflammatory markers continued to rise. A virology screen done showed evidence of previous EBV infection, and in view of poor response to immunosuppression, a superimposed infection was suspected. EBV DNA PCR done on colonic biopsies was found to be positive and the patient was started on intravenous ganciclovir to which he responded well. This case highlights the importance of considering a superimposed infection in patients with poor initial response to steroid therapy in inflammatory bowel disease.
我们报告了一例21岁免疫功能正常的男性患者,患有溃疡性结肠炎并叠加了爱泼斯坦-巴尔病毒(EBV)结肠炎。他首次出现症状为便血性腹泻和炎症指标升高。其内镜和组织学表现被发现是由溃疡性结肠炎所致,为此他开始接受静脉注射类固醇的标准治疗。尽管如此,他仍有症状,炎症指标持续升高。病毒学筛查显示有既往EBV感染的证据,鉴于对免疫抑制反应不佳,怀疑存在叠加感染。对结肠活检进行的EBV DNA聚合酶链反应(PCR)检测呈阳性,患者开始接受静脉注射更昔洛韦治疗,对此他反应良好。该病例凸显了在炎症性肠病患者中,对于初始类固醇治疗反应不佳时考虑叠加感染的重要性。